Evolus (EOLS) Cash from Operations (2017 - 2026)
Evolus' (EOLS) quarterly Cash from Operations came in at 9952000.0 in Q1 2026, up 36.34% YoY from 7299627.63 in Q1 2025, and down 177.59% on a QoQ basis from 12827000.0 in Q4 2025.
Evolus (EOLS) Cash from Operations (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Cash from Operations data on file, last reported at 9952000.0 in Q1 2026.
- Quarterly Cash from Operations rose 36.34% year-over-year to 9952000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36585000.0 (down 58.95% YoY) and the FY2025 annual result came in at 42265000.0, down 134.82% from the prior year.
- Cash from Operations declined to 9952000.0 in Q1 2026, from 12827000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 12827000.0 in Q4 2025 to a low of 38199000.0 in Q1 2022.
- A 5-year average of 11125647.06 and a median of 10615000.0 in 2024 frame the typical range for Cash from Operations.
- The widest YoY moves for Cash from Operations: up 491.39% in 2024, down 519.26% in 2024.
- Tracing EOLS's Cash from Operations over 5 years: stood at 8774000.0 in 2022, then surged by 109.27% to 813000.0 in 2023, then surged by 491.39% to 4808000.0 in 2024, then surged by 166.78% to 12827000.0 in 2025, then plunged by 177.59% to 9952000.0 in 2026.
- The last three Cash from Operations figures came in at 9952000.0 (Q1 2026), 12827000.0 (Q4 2025), and 14669000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 549.85 Mn | 504.68 Mn | 57.18 Mn | -3.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.59 Mn |
| Jun 30, 2026 | -3.59 Mn |
| Mar 31, 2026 | -9.95 Mn |
| Mar 31, 2026 | -9.95 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Dec 31, 2025 | 12.83 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Sep 30, 2025 | -14.67 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Jun 30, 2025 | -24.79 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Mar 31, 2025 | -15.63 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Jun 30, 2024 | -6.47 Mn |
| Mar 31, 2024 | -10.62 Mn |
| Mar 31, 2024 | -10.62 Mn |